IBEX (NASDAQ:IBEX) Insider Paul Joseph Inson Sells 6,994 Shares of Company Stock

IBEX Limited (NASDAQ:IBEX) insider Paul Inson sold 6,994 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $50.73, for a total transaction of $354,805.62. Following the completion of the sale, the insider directly owned 26,550 shares of the company’s stock, valued at approximately $1,346,881.50. This represents a 20.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Paul Joseph Inson also recently made the following trade(s):

• On Wednesday, September 16th, Paul Inson sold 2,500 shares of IBEX stock. The shares were sold at an average price of $40.07, for a total transaction of $100,175.00.
• On Monday, September 14th, Paul Inson sold 2,274 shares of IBEX stock. The shares were sold at an average price of $40.00, for a total transaction of $90,960.00.

IBEX Price Performance

NASDAQ IBEX opened at $52.23 on Wednesday. IBEX Limited has a 12 month low of $25.94 and a 12 month high of $52.29. The firm has a market capitalization of $696.23 million, a PE ratio of 15.83 and a beta of 0.74. The company’s 50 day simple moving average is $43.52 and its 200 day simple moving average is $34.63.

IBEX (NASDAQ:IBEX) last announced its earnings results on Thursday, November 5th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.90 by $0.20. The firm had revenue of $175.23 million for the quarter, compared to analysts’ expectations of $169.31 million. IBEX had a return on equity of 29.10% and a net margin of 7.34%.

Key Headlines Impacting IBEX

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
• Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
• Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
• Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

Analysts Set New Price Targets

A number of research firms have recently commented on IBEX. Wall Street Zen raised IBEX from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Robert W. Baird upped their price objective on IBEX from $40.00 to $44.00 and gave the company a “neutral” rating in a report on Monday, September 28th. Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, October 12th. Finally, Royal Bank Of Canada raised their target price on IBEX from $40.00 to $45.00 and gave the company a “sector perform” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $44.50.

Hedge Funds Weigh In On IBEX

Several hedge funds have recently made changes to their positions in the business. Boston Partners raised its holdings in shares of IBEX by 15.3% in the 3rd quarter. Boston Partners now owns 397,353 shares of the company’s stock worth $17,189,000 after purchasing an additional 52,638 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in IBEX by 7.5% during the first quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company’s stock worth $9,607,000 after buying an additional 24,942 shares in the last quarter. Tieton Capital Management LLC bought a new stake in IBEX during the second quarter worth approximately $8,353,000. Hillsdale Investment Management Inc. boosted its holdings in IBEX by 2.8% during the first quarter. Hillsdale Investment Management Inc. now owns 264,200 shares of the company’s stock worth $7,086,000 after buying an additional 7,300 shares in the last quarter. Finally, Pinnacle Associates Ltd. grew its position in IBEX by 3.4% in the third quarter. Pinnacle Associates Ltd. now owns 208,027 shares of the company’s stock worth $8,999,000 after buying an additional 6,932 shares during the last quarter. Institutional investors and hedge funds own 81.24% of the company’s stock.

About IBEX

IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.